Patterns and risk factors for noncompliance with HMG-CoA inhibitors in a managed care population

被引：0
|
作者：
Yu, AP [1 ]
Nichol, MB [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1046/j.1524-4733.2003.00631.x
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [21] HMG-CoA reductase inhibitors and the kidney
    Campese, VA
    Hadaya, B
    Chiu, J
    CURRENT HYPERTENSION REPORTS, 2005, 7 (05) : 337 - 342
  • [22] HMG-CoA reductase inhibitors and the kidney
    Campese, V. M.
    Park, J.
    KIDNEY INTERNATIONAL, 2007, 71 (12) : 1215 - 1222
  • [23] Syntheses of HMG-CoA reductase inhibitors
    Nissan Chemical Industries, Ltd, Chiba, Japan
    Yuki Gosei Kagaku Kyokaishi, 3 (186-196):
  • [24] IMIDAZOLES AS HMG-COA REDUCTASE INHIBITORS
    WAREING, JR
    LEGINUS, JM
    SCALLEN, TJ
    LINDER, J
    LEE, GT
    STABLER, R
    MARTIN, M
    WIDLER, L
    MYERS, SW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 106 - MEDI
  • [25] SYNTHESES OF HMG-COA REDUCTASE INHIBITORS
    MIYACHI, N
    SUZUKI, M
    OHARA, Y
    HIYAMA, T
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1995, 53 (03) : 186 - 196
  • [26] HMG-CoA Reductase Inhibitors in OsteoporosisDo They Reduce the Risk of Fracture?
    Raymond G. Schlienger
    Christoph R. Meier
    Drugs & Aging, 2003, 20 : 321 - 336
  • [27] Cost effectiveness analysis of HMG-COA reductase inhibitors in a medicaid population
    MacLean, EA
    Moffitt, CM
    VALUE IN HEALTH, 2003, 6 (03) : 319 - 320
  • [28] Inadequate treatment with HMG-CoA reductase inhibitors by health care providers
    Marcelino, JJ
    Feingold, KR
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06): : 605 - 610
  • [29] Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors
    Samizo, Shigeyoshi
    Kaneko, Hiromasa
    ACS OMEGA, 2023, 8 (30): : 27247 - 27255
  • [30] Risk of osteoporosis associated with HMG-COA reductase inhibitors in patients with dyslipidemia
    Yang, Hyeri
    Choi, Eunmi
    Shim, Dayoung
    Kim, Bonggi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 588 - 588
12345